Thread: ACAD - Acadia Pharmaceuticals Inc

Results 1 to 2 of 2

  1. #1

    Default ACAD - Acadia Pharmaceuticals Inc

    About ACADIA Pharmaceuticals

    ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is developing a portfolio consisting of five product candidates, including pimavanserin in Phase III for Parkinson’s disease psychosis, a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, and two programs in IND-track development. All of the product candidates in ACADIA’s pipeline emanate from discoveries made using its proprietary drug discovery platform. ACADIA maintains a website at www.acadia-pharm.com to which ACADIA regularly posts copies of its press releases as well as additional information and through which interested parties can subscribe to receive email alerts.
  2. #2

    Default

    Has reached a high so far of $3.02 PM

    Was looking at this one even had it on a watchlist but didn't pull the trigger. Oh well...

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts